Therapy for fibrocystic breast disease in patients with uterine myoma
Examination of 112 patients with uterine myoma revealed the high rate of concomitance of uterine and breast hyperplastic processes due to the commonness of the pathogenesis of these processes. Different forms of fibrocystic disease (FCD) were identified in 76.8% of the patients with uterine myoma; d...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-08-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/213 |
| _version_ | 1797876059068170240 |
|---|---|
| author | N. V. Kulagina |
| author_facet | N. V. Kulagina |
| author_sort | N. V. Kulagina |
| collection | DOAJ |
| description | Examination of 112 patients with uterine myoma revealed the high rate of concomitance of uterine and breast hyperplastic processes due to the commonness of the pathogenesis of these processes. Different forms of fibrocystic disease (FCD) were identified in 76.8% of the patients with uterine myoma; diffuse FCD with a predominance of a fibrous component was more common (54.7%). The efficacy of Indinol in the treatment of FCD was evaluated in the patients with uterine myoma. The clinical symptoms of mastodynia were relieved in 63.4% of the patients; 33.7% of the women had positive X-ray changes a year after start of therapy, as evidenced by mammography. |
| first_indexed | 2024-04-10T01:57:22Z |
| format | Article |
| id | doaj.art-333f74ad95064abdb305fbee2d1d7b23 |
| institution | Directory Open Access Journal |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| last_indexed | 2024-04-10T01:57:22Z |
| publishDate | 2014-08-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj.art-333f74ad95064abdb305fbee2d1d7b232023-03-13T08:44:33ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-0101404310.17650/1994-4098-2010-0-1-40-43229Therapy for fibrocystic breast disease in patients with uterine myomaN. V. Kulagina0Кафедра акушерства и гинекологии No2 МАПО, Санкт-ПетербургExamination of 112 patients with uterine myoma revealed the high rate of concomitance of uterine and breast hyperplastic processes due to the commonness of the pathogenesis of these processes. Different forms of fibrocystic disease (FCD) were identified in 76.8% of the patients with uterine myoma; diffuse FCD with a predominance of a fibrous component was more common (54.7%). The efficacy of Indinol in the treatment of FCD was evaluated in the patients with uterine myoma. The clinical symptoms of mastodynia were relieved in 63.4% of the patients; 33.7% of the women had positive X-ray changes a year after start of therapy, as evidenced by mammography.https://ojrs.abvpress.ru/ojrs/article/view/213фиброзно-кистозная болезньмиома маткиконсервативная негормональная терапияиндинол |
| spellingShingle | N. V. Kulagina Therapy for fibrocystic breast disease in patients with uterine myoma Опухоли женской репродуктивной системы фиброзно-кистозная болезнь миома матки консервативная негормональная терапия индинол |
| title | Therapy for fibrocystic breast disease in patients with uterine myoma |
| title_full | Therapy for fibrocystic breast disease in patients with uterine myoma |
| title_fullStr | Therapy for fibrocystic breast disease in patients with uterine myoma |
| title_full_unstemmed | Therapy for fibrocystic breast disease in patients with uterine myoma |
| title_short | Therapy for fibrocystic breast disease in patients with uterine myoma |
| title_sort | therapy for fibrocystic breast disease in patients with uterine myoma |
| topic | фиброзно-кистозная болезнь миома матки консервативная негормональная терапия индинол |
| url | https://ojrs.abvpress.ru/ojrs/article/view/213 |
| work_keys_str_mv | AT nvkulagina therapyforfibrocysticbreastdiseaseinpatientswithuterinemyoma |